Hunter Associates »

Trinity Biotech shares owned by Hunter Associates

Quarter-by-quarter ownership of Trinity Biotech shares owned by Hunter Associates from 13F filings

Historical chart of Hunter Associates investment in Trinity Biotech

Tip: Access up to 7 years of quarterly data

All positions including Trinity Biotech held by Hunter Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trinity Biotech by Hunter Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $644k 318k 2.03

More positions owned by Hunter Associates

Microsoft Corporation (MSFT)
Apple (AAPL)
Goldman Sachs Etf Tr Activebeta U S Large Cap Equity Etf Etf (GSLC)
Wisdomtree Tr Intl Hedged Quality Divid Growth Etf (IHDG)
Amgen (AMGN)
Fiserv (FI)
T. Rowe Price (TROW)
Schwab Strategic Tr Us Dividend Equity Etf Etf (SCHD)
Invesco Exchanged Traded Fd Tr Ii Nasdaq 100 Etf Etf (QQQM)
Ishares Tr Core 1-5 Yr Usd Bd Etf Etf (ISTB)
ResMed (RMD)
Fidelity Merrimack Str Tr Total Bd Etf Etf (FBND)
Accenture (ACN)
Procter & Gamble Company (PG)
Pepsi (PEP)

View all positions for Hunter Associates

Top funds holding Trinity Biotech

Perceptive Advisors
Hunter Associates
Stonehill Capital Management
Acadian Asset Management
Whitefort Capital Management
Moss Adams Wealth Advisors
Cambridge Investment Research Advisors
Becker Capital Management
Susquehanna International
UBS Group
Morgan Stanley
Global Retirement Partners
Rhumbline Advisers
CGC Financial Services
Bank of America Corporation

View all funds holding Trinity Biotech